Published in Cancer Weekly, December 7th, 2004
Launched in August 2004, the collaboration brings together Tripos' knowledge-driven chemistry expertise and NovaScreen's assay development and biological screening capabilities to provide Strida with drug discovery support. Tripos will identify, design and synthesize suitable compounds for biological activity assessment in an MTHFR assay developed by NovaScreen. Tripos and NovaScreen will work together to develop primary...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.